Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Price:
41.975 USD
-2.97%
Market Closed
Updated:
May 29, 2024
Amphastar Pharmaceuticals Inc
Other Liabilities
|
Amphastar Pharmaceuticals Inc
Other Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Other Liabilities
$52.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
29%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Liabilities
$25B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Liabilities
$6.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Liabilities
$25.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Liabilities
$8.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Liabilities
$7.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is Amphastar Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
52.8m
USD
52.8m
USD
Based on the financial report for Mar 31, 2024, Amphastar Pharmaceuticals Inc's Other Liabilities amounts to 52.8m USD.
What is Amphastar Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
29%
29%
Over the last year, the Other Liabilities growth was 14%. The average annual Other Liabilities growth rates for Amphastar Pharmaceuticals Inc have been 15% over the past three years , 21% over the past five years , and 29% over the past ten years .
You don't have any saved screeners yet
